In the lung cancer cell lines c-Myc retained an even greater proportion of its solo-controlled mRNAs, while mutants of KRAS and p53 were strongly redundant with c-Myc (Supplementary Fig. 6A–C). This evidence concerns the gene KRAS and lung carcinoma.